对产前阿片类药物暴露的系统研究:神经发育后果的审查
1Neuroscience and Behavioral Biology Department, Emory University, Atlanta, GA; and.
Journal of developmental and behavioral pediatrics : JDBP
|August 27, 2025
概括
产前阿片类药物暴露对神经发育构成风险,特别是在神经感官和社会情感领域. 母亲使用阿片类药物需要监测儿童的神经发育.
科学领域:
- 神经科学
- 发展心理学
- 公共卫生
背景情况:
- 产前阿片类药物暴露对儿童发育的潜在长期影响越来越令人担忧.
- 了解特定的神经发育影响对于早期干预和支持至关重要.
研究的目的:
- 系统地审查和评估与产前阿片类药物暴露相关的不良神经发育影响.
- 综合各种神经行为和神经成像领域的发现.
主要方法:
- 系统审查遵循系统审查和元分析 (PRISMA) 准则的优先报告项目.
- 包括86项研究,使用推,评估,发展和评估 (GRADE) 系统进行评估.
- 结果分为6个神经行为领域和1个神经成像领域.
主要成果:
- 在产前阿片类药物暴露的儿童中,神经感官领域的损伤风险最高 (76. 9%).
- 社会情感领域显示了负面影响的最大效应大小 (Hedge的g=-1.14).
- 神经成像研究是有限的和异质的,阻碍了最终的结论.
结论:
- 孕妇在怀孕期间使用阿片类药物是发育监测的风险指标.
- 由于同时使用物质和社会逆境等混因素,很难确定直接的致病性影响.
更多相关视频
15:27Construction of Vapor Chambers Used to Expose Mice to Alcohol During the Equivalent of all Three Trimesters of Human Development
Published on: July 13, 2014
14.8K
05:13Preclinical Model of Prenatal Delta-9-Tetrahydrocannabinol Exposure to Assess Its Impact on Neurodevelopmental Outcomes
Published on: February 28, 2025
329
相关概念视频
Teratogenicity
4.2K
The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
4.2K
Drug Abuse and Addiction: Pharmacological Phenomena
1.6K
Drug dependence, abuse, and addiction are complex phenomena that can precipitate various abnormal states. Physical dependence refers to a state of pharmacological adaptation to a drug. This adaptation often results in tolerance—a reduced response to the drug after repeated administrations. When the drug use is abruptly stopped, withdrawal symptoms occur due to the body's need to readjust from the pharmacologically induced imbalance. However, tolerance and withdrawal symptoms do not...
1.6K
Opioid Receptors: Overview
7.2K
Opioid receptors, including the mu (μ, MOR), delta (δ, DOR), and kappa (κ, KOR) types, belong to the rhodopsin family of G protein-coupled receptors. These receptors are located throughout the central and peripheral nervous systems and in non-neuronal tissues such as macrophages and astrocytes. Opioid receptor ligands can be categorized into agonists or antagonists. Highly selective agonists include [d-Ala2, MePhe4, Gly(ol)5]-enkephalin or DAMGO for MOR, [D-Pen2,...
7.2K
Analgesia and Pain Management
3.3K
Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
3.3K
Opioid Analgesics: Morphine and Other Natural Cogeners
1.7K
Opioids are a class of drugs that mimic endogenous opioid peptides and act on opioid receptors, and help in pain relief. These compounds are classified as natural, synthetic, or semi-synthetic. Natural opioids, like morphine, codeine, and thebaine, are derived from the opium poppy plant (Papaver somniferum or Papaver album) and are termed opiates. Synthetic opioids are artificial, while semi-synthetic opioids combine natural and synthetic compounds. Morphine, a prototypical opioid, possesses a...
1.7K
